Scientists, health leaders, and politicians alike have described COP26 as our last, best chance to slow global warming and stave off some of the worst health effects of climate change. But the political environment remains fraught. And it’s unclear how rhetoric will translate into action.
Our expert panel brings together leading voices in the fight against climate change, fresh from the halls of the COP26 Summit. They’ll talk through key outcomes and next steps. Bring questions!
Artificial intelligence (AI) is rapidly permeating many facets of our lives, raising both hope and concern about possibilities for our future. AI is transforming domains as disparate as science, medicine, commerce, government, law, the military, and the arts, and in doing so, it is forcing us to grapple with practical, political, and philosophical questions about humans and the nature of human interaction. The Harvard Radcliffe Institute Science Symposium, featuring speakers from disparate disciplines and industries, will examine AI, its impact, and its ethics by exploring current and...
Radcliffe Institute for Advanced Study at Harvard—Online
Alexey Golubev, assistant professor of Russian history and digital humanities at the University of Houston, is working on a new book project: a history of Soviet efforts to produce mass scientific literacy after World War II, when tens and later hundreds of thousands of members of the Soviet intelligentsia were recruited to communicate scientific knowledge to the public through popular science lectures, publications, public experiments and debates, and television shows.
This mass scientific literacy campaign resulted in a diverse and autonomous network of people and ideas in...
The COVID-19 pandemic has affected almost all aspects of life in the United States and around the world, disrupting the global economy as well as countless institutions. The issues raised by the COVID-19 pandemic present a critical juncture for the U.S. and other countries around the world. Our actions now have the potential to shape responses to future pandemics, and to ensure institutions serve all of our populations.
How have our institutions, including the structure of our health care system and its attendant regulations, affected the evolution of the pandemic? What...
Apps for health, wellness and disease management are increasingly common across the healthcare ecosystem. Health systems, biotech and pharma, payers and pharmacy benefits managers are just a few of the industry sectors actively using digital tools to try to improve care delivery and outcomes.
This webinar will discuss emerging lessons and concepts from this space. What is the practical significance of the designation “digital therapeutic?” What are the current regulatory pathways? How does reimbursement actually work? Megan Jones Bell, MD, Chief Science Officer for Headspace,...
Radcliffe Institute for Advanced Study, Knafel Center, 10 Garden St., Cambridge
From Botox to bionic limbs, the human body is more upgradable than ever. But how much can we alter and still be human? The award-winning documentary Fixed: The Science/Fiction of Human Enhancement explores the social impact of human biotechnologies. Fixed rethinks “disability” and “normalcy” by exploring technologies that promise to change our bodies and minds forever. Join us for a discussion about the ethics of gene editing and disability.
Radcliffe Institute for Advanced Study, Knafel Center, 10 Garden Street, Cambridge
Xenotransplantation is a promising strategy to address the shortage of organs for human transplantation, though concerns about pig-to-human immunological compatibility and the risk of cross-species transmission of porcine endogenous retroviruses (PERVs) have impeded the clinical application of this approach. In this lecture, Luhan Yang, cofounder and chief scientific officer of eGenesis will explain how CRISPR is being used to create pigs with advanced immunological modifications to address immunological and functional compatibility issues.
Online webcast from The Forum at Harvard T.H. Chan School of Public Health
In the last decade, Americans’ relationship with cannabis has transformed: today, dozens of states have legalized marijuana for medical or recreational use and American farmers can grow hemp on an industrial scale. Meanwhile, shoppers can find cannabidiol (CBD), which is derived from cannabis but does not produce a “high” like marijuana, in everything from oils to vapes, chocolate bars, cosmetics—even dog treats. Some say CBD can relieve stress, pain, anxiety, and more, with no side effects. But the evidence for many of these claims is limited, and state and federal laws around the sale...
Geological Lecture Hall, 24 Oxford Street, Cambridge, MA
Christopher A. Walsh, Bullard Professor of Pediatrics and Neurology, Harvard Medical School; Chief, Division of Genetics and Genomics, Boston Children’s Hospital; Investigator, Howard Hughes Medical Institute; Associate Member, Broad Institute of Harvard and MIT
Despite major scientific advances in sequencing the genomes of species through the animal kingdom, it has been remarkably difficult to identify the genes that enable the unique cultural, aesthetic, and reasoning capabilities of humans. Christopher Walsh will discuss how research on specific genes...
Epidemic disease spreads quickly in our interconnected, globalized world. This symposium looks at new ways of tracking epidemics using big data and social networks to predict and stem the rise of emergent diseases.... Read more about Contagion: Exploring Modern Epidemics